GGP modified daunorubicin plus dioscin liposomes inhibit breast cancer by suppressing epithelial–mesenchymal transition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GGP modified daunorubicin plus dioscin liposomes inhibit breast cancer by suppressing epithelial–mesenchymal transition

Published:2020-05-18 Issue:6 Volume:46 Page:916-930
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Yao Xue-min¹,Niu Feng-ju²,Kong Liang¹,Cai Fu-yi¹,Jing Ming¹,Fu Min¹,Liu Jing-jing¹,He Si-yu¹,Zhang Lu¹,Liu Xin-ze¹,Ju Rui-jun³,Li Xue-tao¹

Affiliation:

1. School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, China;

2. Health Protection Center, Affiliated Hospital of Shandong Academy of Traditional Chinese Medicine, Jinan, China;

3. Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2020.1763397

Reference47 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer

3. Tumor endothelial cells accelerate tumor metastasis

4. P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells

5. EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiopep-2 modified dual drug-loaded liposomes with brain targeting functionality mitigate Alzheimer’s disease-related symptoms in APP/PS-1 mice;Journal of Drug Targeting;2023-05-25

2. Efficient Delivery of Gemcitabine by Estrogen Receptor-Targeted PEGylated Liposome and Its Anti-Lung Cancer Activity In Vivo and In Vitro;Pharmaceutics;2023-03-19

3. Linggui Zhugan Decoction Delayed the Progression of NAFLD-HCC by Regulating Fatty Acid Metabolism Through AKT/mTOR/SREBP-1/SCD-1 Signaling Pathway;2023

4. Exploring the Therapeutic Potential of Anticancer Heterocyclic Compounds: Role in Nanoscale Pharmacotherapy;Critical Reviews™ in Therapeutic Drug Carrier Systems;2023

5. Dioscin: A review on pharmacological properties and therapeutic values;BioFactors;2021-12-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3